Skip to main content

Global Tissue Engineering Market Is Estimated To Witness High Growth Owing To Increasing Incidence of Chronic Diseases & Technological Advancements

 

Tissue Engineering Market 

The global tissue engineering market is estimated to be valued at US$ 9,436.0 million in 2022 and is expected to exhibit a CAGR of 11.7% over the forecast period of 2022-2030, as highlighted in a new report published by Coherent Market Insights.

 

A) Market Overview:

Tissue engineering involves the development of artificial organs, tissues, and cells to replace or repair damaged tissues or organs in the human body. The rising incidence of chronic diseases, such as cardiovascular diseases, diabetes, and cancer, is driving the demand for tissue engineering. The use of tissue engineering in the field of regenerative medicine has gained significant attention, as it offers potential solutions for organ and tissue failure. Tissue engineering products are also used for drug discovery and testing, stem cell research, and personalized medicine.

 

B) Market Dynamics:

The tissue engineering market is driven by two major factors. Firstly, the increasing incidence of chronic diseases has led to a growing demand for tissue engineering products. For instance, cardiovascular diseases account for a significant number of deaths worldwide, and tissue engineering offers potential solutions for the repair or replacement of damaged heart tissues. Secondly, technological advancements in tissue engineering techniques and materials have improved the success rate of tissue regeneration. For example, the development of 3D bioprinting technology has revolutionized tissue engineering by enabling the fabrication of complex tissues with precise control over their structures.

 

C) Segment Analysis:

The tissue engineering market can be segmented based on the type of product, application, and end-user. Among the product types, the biomaterial segment dominates the market, owing to the wide range of applications of biomaterials in tissue engineering. Within the biomaterial segment, synthetic materials are expected to dominate due to their advantages such as controllable mechanical and degradation properties. In terms of application, orthopedics holds the largest share in the market, as tissue engineering has found widespread use in bone and cartilage repair. The hospital segment dominates the end-user segment due to the high adoption of tissue engineering products in healthcare facilities.

 

D) PEST Analysis:

- Political: The regulatory environment plays a crucial role in the tissue engineering market, as the approval process for tissue engineering products involves compliance with stringent regulations.

- Economic: The increasing healthcare expenditure and rising disposable income in emerging economies are driving the growth of the tissue engineering market.

- Social: The aging population and the increasing prevalence of chronic diseases are creating a significant demand for tissue engineering products.

- Technological: Advancements in bioprinting technology and tissue engineering techniques have improved the outcomes of tissue regeneration.

 

E) Key Takeaways:

- The global tissue engineering market is expected to witness high growth, exhibiting a CAGR of 11.7% over the forecast period, due to increasing incidence of chronic diseases and technological advancements.

- North America is the dominating region in the tissue engineering market, owing to the presence of major key players and favorable reimbursement policies.

- Key players operating in the global tissue engineering market include Acelity L.P. Inc., Allergan Plc., Athersys, Inc., B. Braun, BioMimetic Therapeutics, Bio Tissue Technologies, C. R. Bard, International Stem Cell, Integra Lifesciences, Medtronic, Inc., Organogenesis Inc., Osiris Therapeutics, RTI Surgical, Inc., Stryker Corporation, Tissue Regenix Group Plc., and Zimmer Biomet. These companies are actively engaged in research and development activities to introduce innovative tissue engineering products and strengthen their market presence.

Labels:

Comments

Post a Comment

Popular posts from this blog

Revolutionizing Medicine: Exploring the Growing Bacteriophage Therapy Market

  Bacteriophage Therapy Market In recent years, medical science has witnessed a remarkable revolution in the field of infectious disease treatment - the rise of bacteriophage therapy. As antibiotic resistance continues to pose a global health threat, scientists and researchers are turning their attention to these tiny but powerful viruses to combat stubborn bacterial infections. What are Bacteriophages? Bacteriophages, or simply phages, are naturally occurring viruses that exclusively infect and kill bacteria. They have coexisted with bacteria for billions of years, playing a crucial role in maintaining microbial balance in nature. Harnessing this unique ability, scientists have now turned to phages as a promising alternative to antibiotics, especially against antibiotic-resistant superbugs that conventional medications struggle to combat. According to Coherent Market Insights, The global bacteriophage therapy market is estimated to be valued at US$ 1,148.6 million in 2020 and...
Post a Comment
Read more

Demystifying the Global Micro Guide Catheters Market: Trends and Forecasts

  Micro Guide Catheters Market The medical device industry is witnessing a paradigm shift, with advancements in technology driving innovation in various sectors. One such area that is gaining prominence is the micro guide catheters market. These tiny, flexible instruments have proven instrumental in navigating intricate vascular pathways and performing precise interventions. Trend 1: Miniaturization and Enhanced Flexibility As medical procedures become less invasive, the demand for micro guide catheters has surged. These catheters are designed to access the most challenging anatomical structures, providing medical professionals with greater precision and control during interventions. Miniaturization of the catheters allows for smoother navigation through tortuous vessels, minimizing the risk of vessel damage and reducing patient discomfort. Trend 2: Expanding Applications Initially, micro guide catheters found primary use in neurovascular interventions. However, their versa...
Post a Comment
Read more

Bile Duct Cancer Market: Increasing Awareness and Advances in Treatment Drive Market Growth

Bile Duct Cancer Market  The global Bile Duct Cancer Market is estimated to be valued at US$185.4 million in 2021 and is expected to exhibit a CAGR of 12.8% over the forecast period 2021-2028, as highlighted in a new report published by Coherent Market Insights. Market Overview: Bile duct cancer, also known as cholangiocarcinoma, is a rare but aggressive form of cancer that affects the bile ducts, which are the tubes that carry bile from the liver to the small intestine. This cancer is challenging to diagnose and treat due to its location and aggressive nature. The market is driven by increasing awareness about bile duct cancer, advancements in diagnostic techniques, and the development of targeted therapies for the treatment of this condition. In terms of product use cases, the market offers various diagnostic tests, including imaging techniques like CT scan, MRI, and endoscopic retrograde cholangiopancreatography (ERCP). Additionally, therapeutic options include surgery, rad...
Post a Comment
Read more